Univariate | Multivariable | |||||
---|---|---|---|---|---|---|
Model 1 | Model 2 | |||||
HR (95% CI) | P-value | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Total population | ||||||
loge Hs-cTnT | 0.99 (0.78–1.29) | 0.99 | 0.87 (0.66–1.15) | 0.34 | 0.90 (0.68–1.19) | 0.46 |
loge Copeptin | 1.08 (0.84–1.39) | 0.54 | 0.88 (0.65–1.20) | 0.42 | 0.92 (0.66–1.28) | 0.62 |
loge NT-proBNP | 1.86 (1.44–2.41) | < 0.001 | 0.96 (0.64–1.43) | 0.84 | 0.88 (0.57–1.36) | 0.57 |
Patients surviving to hospital admission | ||||||
loge Hs-cTnT | 0.96 (0.67–1.38) | 0.83 | 0.85 (0.58–1.25) | 0.41 | 0.87 (0.61–1.26) | 0.48 |
loge Copeptin | 1.40 (0.95–2.06) | 0.093 | 1.20 (0.75–1.93) | 0.45 | 1.07 (0.62–1.83) | 0.81 |
loge NT-proBNP | 1.86 (1.24–2.78) | 0.003 | 0.93 (0.50–1.73) | 0.83 | 0.79 (0.41–1.49) | 0.46 |
VF-patients | ||||||
loge Hs-cTnT | 0.85 (0.59–1.24) | 0.41 | 0.78 (0.52–1.17) | 0.24 | 0.85 (0.56–1.28) | 0.43 |
loge Copeptin | 1.15 (0.81–1.63) | 0.44 | 1.01 (0.67–1.51) | 0.98 | 0.95 (0.60–1.52) | 0.85 |
loge NT-proBNP | 1.67 (1.07–2.60) | 0.023 | 0.84 (0.43–1.64) | 0.61 | 0.51 (0.22–1.19) | 0.12 |